Literature DB >> 31883383

Clinical validation of a new commercial highly sensitive KIT D816V mutation analysis in mastocytosis.

Thomas Kristensen1, Hanne Vestergaard2, Carsten Bindslev-Jensen3,4, Michael Boe Møller1, Sigurd Broesby-Olsen3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31883383     DOI： 10.1111/all.14165

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  1 in total

1.  Adverse Prognostic Impact of the KIT D816V Transcriptional Activity in Advanced Systemic Mastocytosis.

Authors:  Nicole Naumann; Johannes Lübke; Sofie Baumann; Juliana Schwaab; Oliver Hoffmann; Sebastian Kreil; Vito Dangelo; Lukas Reiter; Peter Bugert; Thomas Kristensen; Karl Sotlar; Verena Haselmann; Sven Schneider; Georgia Metzgeroth; Christel Weiss; Henning D Popp; Alice Fabarius; Wolf-Karsten Hofmann; Nicholas C P Cross; Andreas Reiter; Mohamad Jawhar
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.